WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018054846) N 3 -CYCLICALLY SUBSTITUTED THIENOURACILES AND USE THEREOF
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2018/054846    International Application No.:    PCT/EP2017/073504
Publication Date: 29.03.2018 International Filing Date: 18.09.2017
IPC:
C07D 495/04 (2006.01), A61K 31/519 (2006.01), A61P 11/06 (2006.01), A61P 11/08 (2006.01), A61P 35/00 (2006.01), A61P 9/00 (2006.01)
Applicants: BAYER AKTIENGESELLSCHAFT [DE/DE]; Kaiser-Wilhelm-Allee 1 51373 Leverkusen (DE).
BAYER PHARMA AKTIENGESELLSCHAFT [DE/DE]; Müllerstr. 178 13353 Berlin (DE)
Inventors: HÄRTER, Michael; (DE).
KOSEMUND, Dirk; (DE).
CANCHO GRANDE, Yolanda; (DE).
DELBECK, Martina; (DE).
KALTHOF, Bernd; (DE).
LUSTIG, Klemens; (DE).
SÜSSMEIER, Frank; (DE)
Agent: BIP PATENTS; Alfred-Nobel-Str. 10 NRW 40789 Monheim am Rhein (DE)
Priority Data:
16190351.3 23.09.2016 EP
17179105.6 30.06.2017 EP
Title (DE) N3-CYCLISCH SUBSTITUIERTE THIENOURACILE UND IHRE VERWENDUNG
(EN) N 3 -CYCLICALLY SUBSTITUTED THIENOURACILES AND USE THEREOF
(FR) THIÉNO-URACILES À SUBSTITUTION N 3 -CYCLIQUE ET LEUR UTILISATION
Abstract: front page image
(DE)Die vorliegende Anmeldung betrifft neue, in 3 -Position cyclisch substituierte Thieno[2,3-d]-pyrimidin-2,4-dion ("Thienouracil")-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung allein oder in Kombinationen zur Behandlung und/oder Prävention von Krankheiten sowie ihre Verwendung zur Herstellung von Arzneimitteln zur Behandlung und/oder Prävention von Krankheiten, insbesondere zur Behandlung und/oder Prävention von Erkrankungen der Lunge und des Herz-Kreislauf-Systems sowie von Krebserkrankungen.
(EN)The invention relates to novel, in position 3, cyclically substituted thieno[2,3-d]pyrimidine-2,4-dione ("thienouracil")-derivatives, to methods for the production thereof, to the use thereof alone or in combinations for treating and/or preventing diseases, and to the use thereof for producing medicaments for treating and/or for preventing diseases, in particular for treating and/or preventing pulmonary and cardiovascular disorders and cancers.
(FR)La présente invention concerne de nouveaux dérivés de thiéno[2,3-d]pyrimidin-2,4-dione ("thiéno-uracile") à substitution cyclique en position 3, des procédés de production desdits dérivés, leur utilisation seuls ou en associations pour le traitement et/ou la prévention de maladies, ainsi que leur utilisation pour la fabrication de médicaments destinés au traitement et/ou à la prévention de maladies, en particulier au traitement et/ou à la prévention de maladies des poumons et du système cardiovasculaire, ainsi que de cancers.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: German (DE)
Filing Language: German (DE)